Corpus ID: 35980088

Inflammation and treatment resistance in major depression: The perfect storm

@article{Raison2013InflammationAT,
  title={Inflammation and treatment resistance in major depression: The perfect storm},
  author={C. Raison and J. Felger and A. Miller},
  journal={The Psychiatric times},
  year={2013},
  volume={30}
}
Major depression is a disease that affects approximately 20 million adults in the US and has a devastating impact on personal and public health.1 Although successful treatment substantially reduces functional impairment and economic burden, up to one-third of depressed patients are resistant to treatment with conventional antidepressants (eg, serotonin and/or norepinephrine reuptake inhibitors), even in the context of standardized attempts such as switching medications and/or augmenting with… Expand
9 Citations
Role of Inflammation in Depression and Treatment Implications.
  • J. Felger
  • Medicine
  • Handbook of experimental pharmacology
  • 2019
Inflammatory profiles of severe treatment-resistant depression.
Biomarkers of Major Depressive Disorder: Knowing is Half the Battle
The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.
  • J. Felger
  • Medicine
  • Current topics in behavioral neurosciences
  • 2017
Biomarkers of inflammation as predictors of treatment response in depression
Physical activity, sleep, and C-reactive protein as markers of positive health in resilient older men

References

SHOWING 1-10 OF 43 REFERENCES
Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study
Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder
...
1
2
3
4
5
...